HAEMATO AG HAEK.DE Stock
HAEMATO AG Price Chart
HAEMATO AG HAEK.DE Financial and Trading Overview
| HAEMATO AG stock price | 21.4 EUR |
| Previous Close | 24.2 EUR |
| Open | 24 EUR |
| Bid | 23.8 EUR x N/A |
| Ask | 24 EUR x N/A |
| Day's Range | 24 - 24 EUR |
| 52 Week Range | 13.65 - 24 EUR |
| Volume | 226 EUR |
| Avg. Volume | 1.25K EUR |
| Market Cap | 125.5M EUR |
| Beta (5Y Monthly) | 1.257471 |
| PE Ratio (TTM) | 14.906832 |
| EPS (TTM) | 1.85 EUR |
| Forward Dividend & Yield | 1.2 (5.16%) |
| Ex-Dividend Date | July 19, 2023 |
| 1y Target Est | 31.6 EUR |
HAEK.DE Valuation Measures
| Enterprise Value | 105.66M EUR |
| Trailing P/E | 14.906832 |
| Forward P/E | 14.371258 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.505773 |
| Price/Book (mrq) | 0.8525149 |
| Enterprise Value/Revenue | 0.426 |
| Enterprise Value/EBITDA | 11.728 |
Trading Information
HAEMATO AG Stock Price History
| Beta (5Y Monthly) | 1.257471 |
| 52-Week Change | 13.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 24 EUR |
| 52 Week Low | 13.65 EUR |
| 50-Day Moving Average | 19.34 EUR |
| 200-Day Moving Average | 18.11 EUR |
HAEK.DE Share Statistics
| Avg. Volume (3 month) | 1.25K EUR |
| Avg. Daily Volume (10-Days) | 3.92K EUR |
| Shares Outstanding | 5.23M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 1.66% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.2 |
| Trailing Annual Dividend Yield | 4.95% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.70059997 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 3.30% |
| Operating Margin (ttm) | 3.34% |
| Gross Margin | 8.70% |
| EBITDA Margin | 3.63% |
Management Effectiveness
| Return on Assets (ttm) | 2.89% |
| Return on Equity (ttm) | 5.61% |
Income Statement
| Revenue (ttm) | 248.14M EUR |
| Revenue Per Share (ttm) | 47.45 EUR |
| Quarterly Revenue Growth (yoy) | -4.79% |
| Gross Profit (ttm) | 21.61M EUR |
| EBITDA | 9.01M EUR |
| Net Income Avi to Common (ttm) | 8.19M EUR |
| Diluted EPS (ttm) | 1.61 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 23.81M EUR |
| Total Cash Per Share (mrq) | 4.56 EUR |
| Total Debt (mrq) | 5.06M EUR |
| Total Debt/Equity (mrq) | 3.44 EUR |
| Current Ratio (mrq) | 2.587 |
| Book Value Per Share (mrq) | 28.152 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 19.73M EUR |
| Levered Free Cash Flow (ttm) | 17.44M EUR |
Profile of HAEMATO AG
| Country | Germany |
| State | N/A |
| City | Schönefeld |
| Address | Lilienthalstraße 3a |
| ZIP | 12529 |
| Phone | 49 30 897 30 86 70 |
| Website | https://www.haemato.ag |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 47 |
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. It provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, rheumatology, and ophthalmology diseases. The company also develops, manufactures, and distributes diagnostic tests under the HAEMATO brand, and cosmetics under the brand M1 SELECT, as well as supplies third party-products. It serves pharmacies, wholesalers, and clinics. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
Q&A For HAEMATO AG Stock
What is a current HAEK.DE stock price?
HAEMATO AG HAEK.DE stock price today per share is 21.4 EUR.
How to purchase HAEMATO AG stock?
You can buy HAEK.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for HAEMATO AG?
The stock symbol or ticker of HAEMATO AG is HAEK.DE.
Which industry does the HAEMATO AG company belong to?
The HAEMATO AG industry is Drug Manufacturers-Specialty & Generic.
How many shares does HAEMATO AG have in circulation?
The max supply of HAEMATO AG shares is 5.23M.
What is HAEMATO AG Price to Earnings Ratio (PE Ratio)?
HAEMATO AG PE Ratio is 11.56756700 now.
What was HAEMATO AG earnings per share over the trailing 12 months (TTM)?
HAEMATO AG EPS is 1.85 EUR over the trailing 12 months.
Which sector does the HAEMATO AG company belong to?
The HAEMATO AG sector is Healthcare.